Where it comes from
- Made in
- Syncytiotrophoblast of the placenta
- Sent out by
- Continuously, not in pulses; between about 12 and 20 weeks it takes over the mother’s blood from her pituitary, and glucose alters its output
- Acts on
- Maternal liver (IGF-1)
- Maternal fat and muscle (insulin resistance)
- Placenta itself
What it does
In medicine
- A research marker of placental function and fetal growth. It is not measured in routine care and no assay for it is standardised
- Reported raised in severe pre-eclampsia, in the mother’s blood and in cord blood, but not raised when pre-eclampsia came with growth restriction, so it is not a usable test 3
Beyond the body’s own use
- Nobody is given it. Pituitary growth hormone is the medicine; this variant has never been made as a drug, and no trial has tested it
- It is studied as a window on the placenta: because it comes from syncytiotrophoblast and nowhere else, its level in maternal blood is close to a direct count of placental output 1
Sources
- Lacroix et al., Human placental growth hormone, a review, Placenta 2002
- Chellakooty et al., Placental growth hormone and the IGF-I axis in maternal circulation, Journal of Clinical Endocrinology and Metabolism 2004
- Mittal et al., Placental growth hormone is increased in maternal and fetal serum in preeclampsia, Journal of Maternal-Fetal and Neonatal Medicine 2007
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.